Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastrooesophageal junction cancer (ToGA) : a phase 3, open-label, randomised controlled trial

1 Citations

Journal

  • Lancet

    Lancet 376 687-697, 2010

Citations (1)*help

See more

Details 詳細情報について

  • CRID
    1573387450550341248
  • NII Article ID
    10030298311
  • Data Source
    • CiNii Articles

Report a problem

Back to top